$MRK News Nike slips after hours as orders fail to

New Post Public Reply Private Reply Replies (0) Message Board

Dec 21, 2014 at 10:14 AM

$MRK News

Nike slips after hours as orders fail to impress 6:38 p.m. Dec. 18, 2014 - MarketWatch
Merck acquires OncoEthix for up to $375 million 8:41 a.m. Dec. 18, 2014 - Angela Chen
From China to the U.S., a surreal week in business news 9:28 a.m. Dec. 12, 2014 - Marek Fuchs
Human trial of experimental Merck Ebola vaccine is suspended 2:17 p.m. Dec. 11, 2014 - Jeanne Whalen
Restoration Hardware shares jump on earnings beat 6:46 p.m. Dec. 10, 2014 - MarketWatch
Merck drug shrank tumors in some breast cancer patients in trial 8:57 a.m. Dec. 10, 2014 - Peter Loftus
Here are today’s biggest S&P 500 losers ... and five winners 12:51 p.m. Dec. 9, 2014 - Philip van Doorn
H&R Block shares fall on quarterly miss 6:41 p.m. Dec. 8, 2014 - Sue Chang
The S&P 500 recorded its biggest drop in nearly 7 weeks 4:33 p.m. Dec. 8, 2014 - Sara Sjolin
Russell 2000 rattles cage on major resistance 11:15 a.m. Dec. 8, 2014 - Michael Ashbaugh
Dow 18,000 beckons, but a bottom in oil prices does not 7:42 a.m. Dec. 8, 2014 - Shawn Langlois
Newscast: Oil prices plunge 7:38 a.m. Dec. 8, 2014 - MarketWatch
Merck to buy Cubist Pharmaceuticals for $8.4 billion 7:26 a.m. Dec. 8, 2014 - Peter Loftus
Merck to buy Cubist Pharmaceuticals in $9.5 billion deal 7:13 a.m. Dec. 8, 2014 - Tomi Kilgore
Merck & Co. to buy Cubist Pharma in total deal valued at $9.5 billion 7:05 a.m. Dec. 8, 2014 - Carla Mozee
Merck's per-share bid for Cubist's stock is 37% above Friday's closing price 7:03 a.m. Dec. 8, 2014 - Tomi Kilgore
Merck & Co.: Cubist Pharma purchase is a 35% premium to shareholders 7:03 a.m. Dec. 8, 2014 - Carla Mozee
Merck to pay $102 a share for Cubist 7:02 a.m. Dec. 8, 2014 - Tomi Kilgore
Merck agrees to buy Cubist Pharmaceuticals for $9.5 bln including debt 7:02 a.m. Dec. 8, 2014 - Tomi Kilgore
Merck & Co. to buy Cubist Pharma for $102 a share in cash 7:01 a.m. Dec. 8, 2014 - Carla Mozee

Zoetis: Betting The Proverbial Farm? 8:15 a.m. Dec. 20, 2014 - Seeking Alpha
FDA Approves Cubist’s Experimental Antibiotic Zerbaxa 7:06 p.m. Dec. 19, 2014 - The Wall Street Journal Interactive Edition
FDA approves Cubist's Zerbaxa 6:35 p.m. Dec. 19, 2014 - Seeking Alpha
Merck Up on OncoEthix Acquisition Deal, Oncology in Focus - Analyst Blog 5:20 p.m. Dec. 19, 2014 - Zacks.com
FDA Approves AstraZeneca Ovarian Cancer Drug 5:12 p.m. Dec. 19, 2014 - The Wall Street Journal Interactive Edition
Tetraphase Spikes on Encouraging Data on Antibiotic - Analyst Blog 4:19 p.m. Dec. 19, 2014 - Zacks.com
Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More 4:00 p.m. Dec. 19, 2014 - Seeking Alpha
Pharma Favorites to Stand the Trials of 2015 2:29 p.m. Dec. 19, 2014 - Barrons.com
Merrill Lynch Top Healthcare Stock Picks for 2015 2:00 p.m. Dec. 19, 2014 - 247WallSt.com
Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo 10:53 a.m. Dec. 19, 2014 - Seeking Alpha
Bull of the Day: Seattle Genetics (SGEN) - Bull of the Day 1:00 a.m. Dec. 19, 2014 - Zacks.com
U.S. Stocks Surge on Fed Reassurance 8:28 p.m. Dec. 18, 2014 - The Wall Street Journal Interactive Edition
NPS Pharmaceuticals and Shire Up on Takeover Rumors - Analyst Blog 6:30 p.m. Dec. 18, 2014 - Zacks.com
Tetraphase Jumps As 'Superbug' Drug Scores In Trial 10:54 a.m. Dec. 18, 2014 - Investors Business Daily
2014 Healthcare Stock Report Card: Sobek Tracks His Hits and Misses 9:35 a.m. Dec. 18, 2014 - TheStreet.com
China moves ahead with Ebola vaccine trials 8:31 a.m. Dec. 18, 2014 - Seeking Alpha
Merck buys Swiss biotech firm 8:23 a.m. Dec. 18, 2014 - Seeking Alpha
Merck Acquires OncoEthix for Up to $375 Million 8:21 a.m. Dec. 18, 2014 - The Wall Street Journal Interactive Edition
Options Traders Buy the Pullback in Pharmaceuticals Giant Merck 5:45 a.m. Dec. 18, 2014 - TheStreet.com
Merck's 3.2% Yield Is The Only Reason To Own The Stock 12:53 a.m. Dec. 18, 2014 - Seeking Alpha

Alnylam Announces Planned Departure of Chief Business Officer, Laurence Reid, Ph.D. 8:00 a.m. Dec. 19, 2014 - BusinessWire - BZX
Merck Begins Tender Offer to Acquire Cubist 8:00 a.m. Dec. 19, 2014 - BusinessWire - BZX
Electrochromic Glass Market Will Reach $ 2.2 billion by 2020 says New NanoMarkets Report 11:14 a.m. Dec. 18, 2014 - PR Newswire - PRF
New Energy a Little More Insulated to Sharp Drop in Oil than Before 9:53 a.m. Dec. 18, 2014 - ACCESSWIRE
Enumeral and Merck Form Collaboration for Predicting Clinical Drug Response with Human-driven Immune Profiling Platform 8:02 a.m. Dec. 18, 2014 - BusinessWire - BZX
Merck Acquires OncoEthix, a Privately Held Oncology Company Developing Novel BET Inhibitors for Hematological and Solid Cancers 7:30 a.m. Dec. 18, 2014 - BusinessWire - BZX
Hemispherx's Ampligen(R) Provides Anti-Tumor Activity Analogous to Emerging Immune Checkpoint Inhibitors 8:31 a.m. Dec. 16, 2014 - GlobeNewswire
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company 7:07 p.m. Dec. 15, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Cubist Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information 5:07 p.m. Dec. 12, 2014 - BusinessWire - BZX
CBST SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches Investigation of the Board of Directors of Cubist Pharmaceuticals, Inc.in Connection With the Fairness of the Sale of the Companyto Merck & Co. 10:19 a.m. Dec. 12, 2014 - BusinessWire - BZX
Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines 9:10 a.m. Dec. 12, 2014 - PR Newswire - PRF
CBST SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company to Merck & Co. 12:51 p.m. Dec. 10, 2014 - BusinessWire - BZX
Merck Announces Appointment of Dr. Julie Gerberding as Executive Vice President for Strategic Communications, Global Public Policy and Population Health 9:30 a.m. Dec. 10, 2014 - BusinessWire - BZX
International Breast Cancer Study Group, Breast International Group and Merck Announce Opening of International PANACEA Study of Patients with HER2+ Breast Cancer 8:45 a.m. Dec. 10, 2014 - BusinessWire - BZX
Data Investigating KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Patients with Advanced Triple-Negative Breast Cancer Presented at 2014 San Antonio Breast Cancer Symposium 8:30 a.m. Dec. 10, 2014 - BusinessWire - BZX
Acquisition of Cubist Pharmaceuticals, Inc. (CBST) by Merck & Co., Inc. (MRK) May Not Be in Shareholders' Best Interests 9:31 p.m. Dec. 9, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company to Merck & Co. -- CBST 11:49 a.m. Dec. 9, 2014 - PR Newswire - PRF
Ryan & Maniskas, LLP Announces Investigation of Cubist Pharmaceuticals Inc. 10:53 a.m. Dec. 9, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, Merck, Alnylam Pharmaceuticals, Nu Skin Enterprises and Organovo Released By InvestorsObserver 9:31 a.m. Dec. 9, 2014 - PR Newswire - PRF
Merck Statement Regarding CUBICIN Patent Litigation 8:11 a.m. Dec. 9, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mermaid Folklore Meets Revolution in New Short Film

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

York Space Systems Faces Class Action Over Misleading IPO

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

China's Manufacturing: Squeeze or Opportunity?

Analyzing China's Impact on Global Markets Think of China's manufacturing clout and you're likely to picture booming factories, relentless steel, and smoke-churning industries reshaping the global chessboard. But here's the kicker: are they swallowing up room for others, or paving the way for their growth? It’s this debate that took the spotlight at the Asia-Pacific...

See's Candies Data Breach Spurs Legal Scrutiny

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Ice-Rock Avalanches: Future Risks and Urgent Lessons

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

Media Forum Spotlights Asia-Pacific Cooperation

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

ATTACK SHARK Partners with Cloud9 League Team

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Summit Tackles BRI Infrastructure's Role in Global SDGs

A Bold Gathering with Lofty Goals Ever watch a room of world leaders debate the finer nuances of sustainable infrastructure? That's something Singapore pulled off on September 6, 2026, with the Second Global Business Summit on Belt and Road Infrastructure Investment. These aren't just any ordinary suits sitting around in a conference room. We're talking about a dynamic...

Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Creality Rolls Out K3, SPARKX i8 at IFA 2026

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....